Willow Biosciences Inc. (WLLW.TO)
CAD 0.06
(-20.0%)
CAD 0.06
(-20.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.67 Million CAD | -63.23% |
| 2022 | 18.14 Million CAD | -48.17% |
| 2021 | 35.01 Million CAD | 60.15% |
| 2020 | 21.86 Million CAD | -35.47% |
| 2019 | 33.88 Million CAD | 3403.87% |
| 2018 | 967.03 Thousand CAD | 33.53% |
| 2017 | 724.18 Thousand CAD | -57.39% |
| 2016 | 1.69 Million CAD | -29.64% |
| 2015 | 2.41 Million CAD | -0.55% |
| 2014 | 2.42 Million CAD | 1.79% |
| 2013 | 2.38 Million CAD | 11.65% |
| 2012 | 2.13 Million CAD | -29.74% |
| 2011 | 3.04 Million CAD | -18.37% |
| 2010 | 3.72 Million CAD | -33.03% |
| 2009 | 5.56 Million CAD | 27.2% |
| 2008 | 4.37 Million CAD | 42.36% |
| 2007 | 3.07 Million CAD | 394.02% |
| 2006 | 621.91 Thousand CAD | 31.68% |
| 2005 | 472.29 Thousand CAD | 44455.66% |
| 2004 | 1060.00 CAD | 0.0% |
| 2003 | - CAD | -100.0% |
| 2002 | 96.4 Thousand CAD | -2.9% |
| 2001 | 99.27 Thousand CAD | -9.61% |
| 2000 | 109.82 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.57 Million CAD | -31.46% |
| 2024 Q2 | 3.57 Million CAD | -21.8% |
| 2023 Q2 | 11.2 Million CAD | -17.03% |
| 2023 Q4 | 6.67 Million CAD | -21.83% |
| 2023 Q1 | 13.5 Million CAD | -25.6% |
| 2023 Q3 | 8.53 Million CAD | -23.79% |
| 2023 FY | 6.67 Million CAD | -63.23% |
| 2022 Q4 | 18.14 Million CAD | -17.4% |
| 2022 Q2 | 26.19 Million CAD | -13.64% |
| 2022 FY | 18.14 Million CAD | -48.17% |
| 2022 Q1 | 30.33 Million CAD | -13.38% |
| 2022 Q3 | 21.97 Million CAD | -16.12% |
| 2021 Q3 | 41.04 Million CAD | -11.59% |
| 2021 FY | 35.01 Million CAD | 60.15% |
| 2021 Q1 | 52.1 Million CAD | 138.32% |
| 2021 Q2 | 46.42 Million CAD | -10.91% |
| 2021 Q4 | 35.01 Million CAD | -14.68% |
| 2020 Q2 | 19.95 Million CAD | -32.39% |
| 2020 Q4 | 21.86 Million CAD | 36.24% |
| 2020 Q1 | 29.51 Million CAD | -12.9% |
| 2020 Q3 | 16.04 Million CAD | -19.57% |
| 2020 FY | 21.86 Million CAD | -35.47% |
| 2019 Q1 | 843.23 Thousand CAD | -44.6% |
| 2019 Q3 | 38.62 Million CAD | -8.07% |
| 2019 Q2 | 42.01 Million CAD | 4882.66% |
| 2019 Q4 | 33.88 Million CAD | -12.27% |
| 2019 FY | 33.88 Million CAD | 3403.87% |
| 2018 FY | 967.03 Thousand CAD | 33.53% |
| 2018 Q1 | 1.34 Million CAD | -19.27% |
| 2018 Q3 | 1.64 Million CAD | 126.54% |
| 2018 Q4 | 1.52 Million CAD | -7.23% |
| 2018 Q2 | 724.18 Thousand CAD | -45.96% |
| 2017 Q4 | 1.66 Million CAD | 3.71% |
| 2017 Q3 | 1.6 Million CAD | -5.81% |
| 2017 Q2 | 1.69 Million CAD | -43.2% |
| 2017 Q1 | 2.99 Million CAD | -0.47% |
| 2017 FY | 724.18 Thousand CAD | -57.39% |
| 2016 Q1 | 2.79 Million CAD | 8.84% |
| 2016 FY | 1.69 Million CAD | -29.64% |
| 2016 Q3 | 3.02 Million CAD | 25.26% |
| 2016 Q4 | 3 Million CAD | -0.64% |
| 2016 Q2 | 2.41 Million CAD | -13.59% |
| 2015 Q3 | 2.48 Million CAD | 2.43% |
| 2015 Q1 | 2.39 Million CAD | 2.64% |
| 2015 Q2 | 2.42 Million CAD | 1.44% |
| 2015 FY | 2.41 Million CAD | -0.55% |
| 2015 Q4 | 2.56 Million CAD | 3.23% |
| 2014 Q1 | 2.8 Million CAD | -3.01% |
| 2014 Q3 | 2.35 Million CAD | -1.31% |
| 2014 Q4 | 2.33 Million CAD | -0.94% |
| 2014 Q2 | 2.38 Million CAD | -14.8% |
| 2014 FY | 2.42 Million CAD | 1.79% |
| 2013 Q2 | 2.13 Million CAD | -35.97% |
| 2013 FY | 2.38 Million CAD | 11.65% |
| 2013 Q1 | 3.33 Million CAD | -0.6% |
| 2013 Q4 | 2.88 Million CAD | 14.83% |
| 2013 Q3 | 2.51 Million CAD | 17.65% |
| 2012 Q4 | 3.35 Million CAD | 0.44% |
| 2012 FY | 2.13 Million CAD | -29.74% |
| 2012 Q1 | 3.07 Million CAD | 0.95% |
| 2012 Q2 | 3.04 Million CAD | -0.96% |
| 2012 Q3 | 3.34 Million CAD | 9.9% |
| 2011 FY | 3.04 Million CAD | -18.37% |
| 2011 Q4 | 3.04 Million CAD | -17.11% |
| 2011 Q2 | 3.72 Million CAD | -20.96% |
| 2011 Q1 | 4.71 Million CAD | -3.69% |
| 2011 Q3 | 3.67 Million CAD | -1.49% |
| 2010 FY | 3.72 Million CAD | -33.03% |
| 2010 Q1 | 6.49 Million CAD | -3.29% |
| 2010 Q2 | 5.56 Million CAD | -14.36% |
| 2010 Q3 | 6.19 Million CAD | 11.39% |
| 2010 Q4 | 4.89 Million CAD | -21.01% |
| 2009 Q3 | 5.7 Million CAD | 30.33% |
| 2009 FY | 5.56 Million CAD | 27.2% |
| 2009 Q1 | 3.52 Million CAD | -2.15% |
| 2009 Q4 | 6.71 Million CAD | 17.84% |
| 2009 Q2 | 4.37 Million CAD | 23.97% |
| 2008 Q1 | 2.46 Million CAD | -6.32% |
| 2008 Q2 | 3.07 Million CAD | 24.6% |
| 2008 Q3 | 3.99 Million CAD | 29.91% |
| 2008 Q4 | 3.6 Million CAD | -9.67% |
| 2008 FY | 4.37 Million CAD | 42.36% |
| 2007 FY | 3.07 Million CAD | 394.02% |
| 2007 Q4 | 2.63 Million CAD | 186.3% |
| 2007 Q3 | 919.31 Thousand CAD | 47.82% |
| 2007 Q2 | 621.91 Thousand CAD | -0.57% |
| 2007 Q1 | 625.5 Thousand CAD | -9.43% |
| 2006 Q2 | 472.29 Thousand CAD | 31.38% |
| 2006 Q3 | 784.34 Thousand CAD | 66.07% |
| 2006 Q4 | 690.66 Thousand CAD | -11.94% |
| 2006 FY | 621.91 Thousand CAD | 31.68% |
| 2006 Q1 | 359.48 Thousand CAD | 108.93% |
| 2005 Q1 | 515.00 CAD | -94.6% |
| 2005 Q2 | 1060.00 CAD | 105.83% |
| 2005 Q4 | 172.05 Thousand CAD | 16412.28% |
| 2005 Q3 | 1042.00 CAD | -1.7% |
| 2005 FY | 472.29 Thousand CAD | 44455.66% |
| 2004 FY | 1060.00 CAD | 0.0% |
| 2004 Q1 | 104.36 Thousand CAD | 0.0% |
| 2004 Q2 | - CAD | -100.0% |
| 2004 Q3 | 28.00 CAD | 0.0% |
| 2004 Q4 | 9529.00 CAD | 33932.14% |
| 2003 Q3 | 96.38 Thousand CAD | -0.02% |
| 2003 Q4 | 104.36 Thousand CAD | 8.28% |
| 2003 Q1 | 97.09 Thousand CAD | -3.16% |
| 2003 FY | - CAD | -100.0% |
| 2003 Q2 | 96.4 Thousand CAD | -0.72% |
| 2002 Q1 | 104.25 Thousand CAD | 8.04% |
| 2002 FY | 96.4 Thousand CAD | -2.9% |
| 2002 Q4 | 100.26 Thousand CAD | -1.48% |
| 2002 Q3 | 101.77 Thousand CAD | 2.52% |
| 2002 Q2 | 99.27 Thousand CAD | -4.78% |
| 2001 Q2 | 109.82 Thousand CAD | 713.54% |
| 2001 FY | 99.27 Thousand CAD | -9.61% |
| 2001 Q1 | 13.5 Thousand CAD | 0.0% |
| 2001 Q3 | 96.49 Thousand CAD | -12.14% |
| 2001 Q4 | 96.49 Thousand CAD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 2000 FY | 109.82 Thousand CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 99.204% |
| Avicanna Inc. | 21.97 Million CAD | 69.628% |
| Avant Brands Inc. | 82.55 Million CAD | 91.917% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | 81.818% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | 72.872% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 99.294% |
| MediPharm Labs Corp. | 63.93 Million CAD | 89.563% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 97.764% |
| Canopy Growth Corporation | 1.3 Billion CAD | 99.487% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 97.452% |